Comparing heart-procedure approvals, adoption, and outcomes across rich countries
Official title: Comparing approval, adoption/de-adoption and outcomes for advanced cardiovascular procedures across high-income countries
Funded at Harvard Medical School · NIH-11596352 · Data updated 2026-11-12
This project looks at how new cardiovascular procedures are approved, used, and how well they work in high-income countries to understand why outcomes differ.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | February 21, 2024 |
| Project end | January 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $25,920 |
| NIH project number | 3R01HL167887-03S3 |
| Project ID | NIH-11596352 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults with cardiovascular conditions treated by advanced procedures in high-income countries participating in the study.
✕Less likely to help
Patients in systems not yet applying HTA or sharing data may see indirect benefits through broader policy insights.
What this research studies
Researchers at Harvard Medical School will use an existing international research network to compare how different countries evaluate and adopt advanced cardiovascular procedures and how these choices affect patient outcomes. They will analyze health technology assessment processes and link them to real-world use of treatments and to patient results across multiple countries. The work builds on prior international collaboration to study heart disease care and aims to reveal factors behind spending and outcomes differences. The study will use observational data from diverse health systems to identify patterns and potential improvements in decision making for cardiovascular care.
Why it matters
Potential benefit: If successful, this work could inform policy and clinical practice to optimize cardiovascular care and reduce unnecessary spending.
How similar studies have gone: Previous international collaborations have shown that HTA and policy decisions influence treatment adoption and outcomes, supporting this line of research.
Where this research is happening
-
Harvard Medical School
Boston, United States Active
Researchers
- Principal investigator: Landon, Bruce E. — Harvard Medical School
- Study coordinator: Landon, Bruce E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.